000 | 01008 a2200289 4500 | ||
---|---|---|---|
005 | 20250515203110.0 | ||
264 | 0 | _c20100304 | |
008 | 201003s 0 0 fre d | ||
022 | _a0370-629X | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBoxho, G | |
245 | 0 | 0 |
_a[Advances concerning aliskiren, direct renin inhibitor and aliskiren-hydrochlorothiazide]. _h[electronic resource] |
260 |
_bRevue medicale de Liege _cNov 2009 |
||
300 |
_a560-5 p. _bdigital |
||
500 | _aPublication Type: English Abstract; Journal Article | ||
650 | 0 | 4 |
_aAmides _xpharmacology |
650 | 0 | 4 |
_aAntihypertensive Agents _xpharmacology |
650 | 0 | 4 |
_aCardiovascular Diseases _xdrug therapy |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 |
_aDiabetic Nephropathies _xdrug therapy |
650 | 0 | 4 |
_aFumarates _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aRenin _xantagonists & inhibitors |
700 | 1 | _aKrzesinski, J M | |
700 | 1 | _aScheen, A J | |
773 | 0 |
_tRevue medicale de Liege _gvol. 64 _gno. 11 _gp. 560-5 |
|
999 |
_c19448177 _d19448177 |